BWP
GSK icon

Baldwin Wealth Partners’s GSK GSK Stock Holding History

Baldwin Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,140
Closed -$996K – 565
2024
Q3 		$996K Buy
24,140
+23,821
+7,467% +$974K 0.07% 127
2024
Q2 		$12.3K Hold
319
– – ﹤0.01% 520
2024
Q1 		$13.7K Sell
319
-180
-36% -$7.42K ﹤0.01% 531
2023
Q4 		$18.5K Sell
499
-2,806
-85% -$101K ﹤0.01% 507
2023
Q3 		$120K Hold
3,305
– – 0.01% 277
2023
Q2 		$118K Sell
3,305
-29
-0.9% -$1.04K 0.01% 297
2023
Q1 		$119K Buy
3,334
+2,835
+568% +$99.2K 0.01% 305
2022
Q4 		$17.5K Buy
499
+343
+220% +$11.4K ﹤0.01% 553
2022
Q3 		$5K Hold
156
– – ﹤0.01% 560
2022
Q2 		$8K Hold
156
– – ﹤0.01% 553
2022
Q1 		$8K Buy
+156
New +$8.47K ﹤0.01% 558
2021
Q4 		– Sell
-2,807
Closed -$134K – 641
2021
Q3 		$134K Buy
2,807
+119
+4% +$5.98K 0.01% 234
2021
Q2 		$134K Sell
2,688
-109
-4% -$5.24K 0.01% 240
2021
Q1 		$125K Buy
2,797
+61
+2% +$2.77K 0.01% 233
2020
Q4 		$126K Buy
2,736
+124
+5% +$5.7K 0.02% 227
2020
Q3 		$123K Buy
2,612
+1,856
+246% +$93K 0.02% 208
2020
Q2 		$39K Buy
+756
New +$38.8K 0.01% 321
2017
Q4 		– Sell
-182
Closed -$9K – 484
2017
Q3 		$9K Buy
+182
New +$9.23K ﹤0.01% 415
2017
Q2 		– Sell
-217
Closed -$11K – 484
2017
Q1 		$11K Buy
217
+157
+262% +$7.96K ﹤0.01% 417
2016
Q4 		$3K Hold
60
– – ﹤0.01% 480
2016
Q3 		$3K Hold
60
– – ﹤0.01% 499
2016
Q2 		$3K Hold
60
– – ﹤0.01% 430
2016
Q1 		$3K Buy
+60
New +$2.99K ﹤0.01% 455

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Baldwin Wealth Partners's GSK Position: Q4 2024 in Review

Baldwin Wealth Partners sold out of GSK (GSK) in Q4 2024, closing a stake of 24,140 shares — an estimated $996K sold.

Baldwin Wealth Partners first reported a position in GSK in Q1 2016 and held it in 23 quarters. The position peaked at $996K in Q3 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Baldwin Wealth Partners reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 24,140 GSK shares in Q4 2024, an estimated $996K.
  • Baldwin Wealth Partners first reported a position in GSK in Q1 2016 and held it in 23 quarters.
  • Baldwin Wealth Partners's GSK position peaked at $996K in Q3 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Baldwin Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.